相似文献
1
Public choice and public health.公共选择与公共卫生。
Public Choice. 2023;195(1-2):5-41. doi: 10.1007/s11127-021-00900-2. Epub 2021 Mar 22.
2
Public sector reforms and their impact on the level of corruption: A systematic review.公共部门改革及其对腐败程度的影响：一项系统综述。
Campbell Syst Rev. 2021 May 24;17(2):e1173. doi: 10.1002/cl2.1173. eCollection 2021 Jun.
3
Convergence of service, policy, and science toward consumer-driven mental health care.服务、政策与科学向消费者驱动型精神卫生保健的融合。
J Ment Health Policy Econ. 2006 Dec;9(4):185-92.
4
Structural Inequities, Fair Opportunity, and the Allocation of Scarce ICU Resources.结构性不平等、公平机会与稀缺 ICU 资源配置。
Hastings Cent Rep. 2021 Sep;51(5):42-47. doi: 10.1002/hast.1285.
5
THE RIGHT TO HEALTH CARE IN THE CONTEXT OF PUBLIC AND PRIVATE INTERESTS.公共利益和私人利益背景下的医疗保健权利。
Wiad Lek. 2023;76(12):2714-2720. doi: 10.36740/WLek202312123.
6
A scholarly concentration program to promote public health nursing for generalist Clinical Nurse Leader students.促进普通临床护理领导学生公共卫生护理的学术集中计划。
J Prof Nurs. 2021 Mar-Apr;37(2):348-353. doi: 10.1016/j.profnurs.2021.01.005. Epub 2021 Jan 20.
7
"It reflects the society in which we live, except now everything is accentuated": youth, social inequities, and the COVID-19 pandemic.“它反映了我们生活的社会，只是如今一切都被放大了”：青年、社会不平等与新冠疫情。
Can J Public Health. 2022 Dec;113(6):795-805. doi: 10.17269/s41997-022-00703-y. Epub 2022 Sep 30.
8
Role of latent factors and public policies in travel decisions under COVID-19 pandemic: Findings of a hybrid choice model.潜在因素和公共政策在新冠疫情下出行决策中的作用：混合选择模型的研究结果
Sustain Cities Soc. 2022 Mar;78:103601. doi: 10.1016/j.scs.2021.103601. Epub 2021 Dec 16.
9
The politics of managed competition: public abuse of the private interest.管理式竞争的政治：公共对私人利益的滥用。
J Health Polit Policy Law. 2003 Apr-Jun;28(2-3):341-53. doi: 10.1215/03616878-28-2-3-341.
10
Big pharma and health care: unsolvable conflict of interests between private enterprise and public health.大型制药公司与医疗保健：私营企业与公共卫生之间无法解决的利益冲突。
Isr J Psychiatry Relat Sci. 2008;45(2):83-9; discussion 90-4.
引用本文的文献
1
A Framework for Considering the Role of the Public Sector in R&D of Health Technology.一个关于公共部门在卫生技术研发中作用的考量框架。
Pharmaceut Med. 2025 Aug 8. doi: 10.1007/s40290-025-00576-9.
2
From lab to mass production: a policy for enabling the licensing of mRNA vaccines.从实验室到大规模生产：mRNA 疫苗许可的政策。
Front Public Health. 2023 May 18;11:1151713. doi: 10.3389/fpubh.2023.1151713. eCollection 2023.
3
COVID-19 fatalities and internal conflict: Does government economic support matter?新冠疫情死亡人数与内部冲突：政府的经济支持重要吗？
Eur J Polit Econ. 2023 Jun;78:102368. doi: 10.1016/j.ejpoleco.2023.102368. Epub 2023 Feb 24.
4
The political economy of public health.公共卫生的政治经济学
Public Choice. 2023;195(1-2):1-3. doi: 10.1007/s11127-022-01031-y. Epub 2022 Dec 9.
5
The pox of politics: Troesken's tradeoff reexamined.政治的瘟疫：重新审视特罗斯肯的权衡
Public Choice. 2023;195(1-2):169-191. doi: 10.1007/s11127-022-01002-3. Epub 2022 Oct 21.
6
Inframarginal externalities: COVID-19, vaccines, and universal mandates.超边际外部性：新冠疫情、疫苗与普遍强制要求
Public Choice. 2023;195(1-2):55-72. doi: 10.1007/s11127-022-01006-z. Epub 2022 Oct 23.
7
Optimal lockdowns.最佳封锁措施
Public Choice. 2022;193(3-4):263-274. doi: 10.1007/s11127-022-00992-4. Epub 2022 Sep 7.
8
Pandemics, economic freedom, and institutional trade-offs.大流行病、经济自由与制度权衡。
Eur J Law Econ. 2022;54(1):37-61. doi: 10.1007/s10657-021-09704-7. Epub 2021 Jul 19.
9
Epidemic disease and the state: Is there a tradeoff between public health and liberty?流行病与国家：公共卫生和自由之间是否存在权衡？
Public Choice. 2023;195(1-2):145-167. doi: 10.1007/s11127-021-00944-4. Epub 2021 Nov 27.
10
Federalism and pandemic policies: variety as the spice of life.联邦制与疫情政策：多样乃生活之调味剂。
Public Choice. 2023;195(1-2):73-100. doi: 10.1007/s11127-021-00915-9. Epub 2021 Jul 1.
本文引用的文献
1
Politics and health care spending in the United States: A case study from the passage of the 2003 Medicare Modernization Act.美国的政治与医疗保健支出：以 2003 年《医疗保险现代化法案》通过为例的研究
J Health Econ. 2024 May;95:102878. doi: 10.1016/j.jhealeco.2024.102878. Epub 2024 Apr 4.
2
Rents From the Essential Health Benefits Mandate of Health Insurance Reform.医疗保险改革基本健康福利规定所产生的租金。
Health Mark Q. 2015;32(2):197-215. doi: 10.1080/07359683.2015.1033937.
3
Entry and regulation: evidence from health care professions.准入与监管：来自医疗行业的证据
Rand J Econ. 2008 Winter;39(4):949-72. doi: 10.1111/j.1756-2171.2008.00045.x.
4
Interest groups and state Medicaid drug programs.利益集团与州医疗补助药品计划。
J Health Polit Policy Law. 2003 Feb;28(1):9-39. doi: 10.1215/03616878-28-1-9.
5
The politics of discretionary Medicaid spending, 1980-1993.1980 - 1993年可自由支配医疗补助支出的政治因素
J Health Polit Policy Law. 2002 Aug;27(4):639-71. doi: 10.1215/03616878-27-4-639.
6
The economics of AIDS-related health insurance regulations: interest group influence and ideology.艾滋病相关健康保险法规的经济学：利益集团的影响与意识形态
Public Choice. 1992 Jul;74(1):105-26. doi: 10.1007/BF00175213.
7
The economics and ethics of alternative cadaveric organ procurement policies.替代性尸体器官获取政策的经济学与伦理学
Yale J Regul. 1991 Summer;8(2):403-52.
8
The effect of commercial practice restrictions: the case of optometry.商业行为限制的影响：验光行业案例
J Law Econ. 1986;29(1):165-86. doi: 10.1086/467114.
9
Physician licensure: a new approach to examining the role of professional interests.医师执照：一种审视职业利益角色的新方法。
Econ Inq. 1987;25(3):497-509.
10
The strategic use of public policy: business support for the 1906 Food and Drug Act.公共政策的战略运用：企业对1906年《食品和药品法》的支持。
Bus Hist Rev. 1985;59(3):403-32.
Zotero 插件